SEGMENTS INFORMATION (Tables)

3 Months Ended

Mar. 31, 2026

The information below reflects segment structure as of March 31, 2026.


Segment Revenue, Significant Segment Expenses and Segment Operating EBITDA	Three Months Ended March 31,
	2026				2025
In millions	Healthcare & Water Technologies		Diversified Industrials		Healthcare & Water Technologies		Diversified Industrials
Segment net sales	$	806	$	875	$	763	$	849
Less 1:
Cost of sales	$	496	$	571	$	478	$	568
Selling, general and administrative expenses	93		116		85		106
Research and development expenses	22		28		20		23
Amortization of intangibles & other segment items 2	43		24		49		26
Add:
Equity in earnings (loss) of nonconsolidated affiliates	$	1	$	(1)	$	—	$	—
Depreciation and amortization 3	91		65		92		59
Segment operating EBITDA	$	244	$	200	$	223	$	185

1.The significant expense categories and amounts align with the segment-level information that is regularly provided to the chief operating decision maker.

2.Other segment items include immaterial other gains or losses and miscellaneous income and expenses.

3.Depreciation is a reconciling item to Segment Operating EBITDA as it is included within "Cost of sales", "Selling, general and administrative expenses" and "Research and development expenses".

Schedule of Reconciliation of Income from Continuing Operations


Reconciliation of Segment Operating EBITDA to Income from Continuing Operations Before Income Taxes		Three Months Ended March 31,
In millions		2026		2025
Healthcare & Water Technologies Segment Operating EBITDA		$	244	$	223
Diversified Industrials Segment Operating EBITDA		200		185
Total segment operating EBITDA		$	444	$	408
+	Corporate Operating EBITDA 1	$	(30)	$	(48)
-	Depreciation and amortization	155		160
+	Interest income 2	10		17
-	Interest expense 3	40		82
+	Non-operating pension/OPEB benefit credits	—		2
+	Foreign exchange gain (losses), net	10		(3)
-	Future Reimbursable Indirect Costs	8		25
-	Corporate DDOB Remediation Costs	4		3
+	Significant items charge	(46)		(9)
Income from continuing operations before income taxes		$	181	$	97

1.Corporate includes certain enterprise and governance activities including non-allocated corporate overhead costs and support functions, leveraged services, non-business aligned litigation expenses, DuPont's equity interest in Derby related to the Delrin® divestiture and other costs not absorbed by reportable segments.

2.The three months ended March 31, 2025 excludes accrued interest income earned on employee retention credits. Refer to details of significant items below.

3.The three months ended March 31, 2025 excludes interest rate swap basis amortization. Refer to details of significant items below.


Capital Expenditure Reconciliation to Consolidated Financial Statements	Three Months Ended March 31,
In millions	2026		2025
Healthcare & Water Technologies	$	29	$	22
Diversified Industrials	34		22
Segment totals	$	63	$	44
Accrual to cash adjustment 1	39		78
Total	$	102	$	122

1.Reflects the incremental cash spent or unpaid on capital expenditures; total capital expenditures are presented on a cash basis.

Schedule of Pre-Tax Impact Of Significant Items by Segment

The following tables summarize the pre-tax impact of significant items by segment that are excluded from Operating EBITDA above:


Significant Items by Segment for the Three Months Ended March 31, 2026	Healthcare & Water Technologies		Diversified Industrials		Corporate		Total
In millions
Restructuring and asset related charges – net 1	$	(12)	$	(12)	$	(22)	$	(46)



Other benefits (credits), net 2	3		(3)		—		—
Total	$	(9)	$	(15)	$	(22)	$	(46)

1. Includes restructuring actions and asset related charges. See Note 5 for additional information.

2. Includes a benefit related to an adjustment within Healthcare & Water Technologies of the Donatelle contingent earn-out liability ($6 million pre-tax benefit), legal costs within the Healthcare & Water Technologies segment associated with a pending intellectual property matter ($3 million pre-tax cost), and legal costs associated with personal injury cases associated with Corian® Quartz, a product within the Diversified Industrials segment ($3 million pre-tax cost).


Significant Items by Segment for the Three Months Ended March 31, 2025	Healthcare & Water Technologies		Diversified Industrials		Corporate		Total
In millions
Restructuring and asset related charges – net 1	$	(6)	$	(4)	$	(29)	$	(39)
Acquisition, integration and separation costs 2	1		—		(51)		(50)
Interest rate swap mark-to-market gain 3	—		—		77		77
Other benefits (credits), net 4	—		—		3		3
Total	$	(5)	$	(4)	$	—	$	(9)

1. Includes restructuring actions and asset related charges. See Note 5 for additional information.

2. Acquisition, integration and separation costs related primarily to the Electronics Separation.

3. Includes the non-cash mark-to-market gain related to the 2022 Swaps and 2024 Swaps offset by the interest settlement loss on the 2022 Swaps. The three months ended March 31, 2025 also includes basis amortization on the 2022 Swaps ($1 million pre-tax, reflected in "Interest expense" within the interim Consolidated Statements of Operations). Refer to Note 17 for further details.

4. Reflects benefits related to accrued interest earned on employee retention credits.

Schedule of Total Asset Reconciliation


Segment and Corporate Information	Healthcare & Water Technologies		Diversified Industrials		Corporate		Total
In millions
As of March 31, 2026
Assets of continuing operations	$	9,356	$	7,001	$	3,239	$	19,596
Investment in nonconsolidated affiliates	—		(1)		125		124
As of December 31, 2025
Assets of continuing operations	$	9,463	$	7,512	$	2,744	$	19,719
Investment in nonconsolidated affiliates	—		—		111		111